Y. Chen

机构：Hematology Oncology Consultants

发表论文 1 篇 · 总被引 1 次 · h-index 1

代表论文

• 161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) (2023 · Journal of Thoracic Oncology · 被引 1)